Nominations are now open for the 2026 Fiercest Women in Life Sciences. | Who should be a 2026 Fiercest Woman in Life Sciences ...
A ccording to the CBRE U.S. Life Sciences Outlook 2025 report, U.S life sciences employment hit a record high in 2024, and more job growth is expected in 2025. Meanwhile, the life sciences sector ...
Life sciences businesses are very healthy these days. Advances in research, testing, and manufacturing in the pharmaceutical, biotech, medical devices, and related industries continue to generate high ...
The successful IPO of Caris Life Sciences makes its founder David Dean Halbert worth an estimated $3.3 billion. Caris Life Sciences, a cancer diagnostics company based in Irving, Texas, uses gene ...
Johns Hopkins University will invest $80 million annually for each of the next two years in groundbreaking basic and applied research across a vast array of life science disciplines—from immunology to ...
Travelers Companies has completed the nationwide rollout of its Synergy product liability insurance for life sciences ...
Attorneys at Proskauer Rose LLP explain that financings in the life sciences industry need to account for emerging regulatory and market trends and that loan documents can address the issues and ...
As costs and regulatory pressures rise and educated patients clamor for personalized treatment, digital innovations will inexorably alter the life sciences landscape. Michael Townsend, research ...
See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. California is a national leader in innovation. This position is no more ...
London-based international life-science research organisation says the registrations will support scientific cooperation, public-health capacity building and humanitarian initiatives, with a long-term ...
Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...
June 22 (Reuters) - The U.S. Food and Drug Administration has declined to approve Achieve Life Sciences' (ACHV.O), opens new tab drug to treat nicotine dependence in adults, citing unresolved issues ...